Detalhe da pesquisa
1.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589839
2.
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
Breast Cancer Res
; 23(1): 30, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663560
3.
Adjuvant cyclin-dependent kinase 4/6 inhibition in hormone receptor-positive breast cancer: One Monarch to rule them all?
Cancer
; 127(18): 3302-3309, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047359
4.
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Support Care Cancer
; 29(5): 2509-2517, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929540
5.
PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer.
Int J Mol Sci
; 22(21)2021 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34769309
6.
Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 183(2): 411-418, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32671612
7.
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
South Med J
; 113(11): 559-563, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140109
8.
Adjuvant tamoxifen adherence in male patients with breast cancer: An ongoing challenge.
Cancer
; 128(1): 22-24, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597416
9.
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104).
Breast Cancer Res Treat
; 165(2): 375-382, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28623430
10.
Accuracy of Medicare Claim-based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases.
Med Care
; 55(12): e144-e149, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29135778
11.
A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer.
Int J Breast Cancer
; 2024: 5515966, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356965
12.
Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer.
Cancers (Basel)
; 16(3)2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339371
13.
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.
Lancet Oncol
; 13(7): 734-42, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22704583
14.
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.
JAMA Netw Open
; 6(4): e238504, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37083668
15.
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
medRxiv
; 2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945501
16.
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
Breast Cancer Res Treat
; 131(1): 231-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21842243
17.
Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report.
Breast Dis
; 41(1): 255-260, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599460
18.
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer.
Clin Cancer Res
; 28(9): 1854-1862, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110416
19.
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
J Clin Oncol
; 40(4): 345-355, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910554
20.
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
Clin Breast Cancer
; 21(6): 539-551, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154926